The association between PD-1 gene polymorphisms and susceptibility to multiple sclerosis

被引:6
作者
Hassani, Nasrin [1 ]
Salmaninejad, Arash [2 ,3 ]
Aslani, Saeed [3 ,6 ]
Kamali-sarvestani, Eskandar [4 ,5 ]
Vessal, Mahmood [1 ]
机构
[1] Islamic Azad Univ, Fac Med, Dept Mol Biol, Shiraz, Iran
[2] Guilan Univ Med Sci, Sch Med, Razi Hosp, Regenerat Med Organ Procurement & Transplantat Mu, Rasht, Iran
[3] Mashhad Univ Med Sci, Fac Med, Dept Med Genet, Mashhad, Razavi Khorasan, Iran
[4] Shiraz Univ Med Sci, Dept Immunol, Shiraz Med Sch, Shiraz, Iran
[5] Shiraz Univ Med Sci, Autoimmune Dis Res Ctr, Shiraz Med Sch, Shiraz, Iran
[6] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran
关键词
Multiple sclerosis; programmed cell death protein 1; polymorphism; association; PROGRAMMED DEATH-1 GENE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; PDCD1; DISEASE; POPULATION; TOLERANCE; PATHWAY; CELLS;
D O I
10.1080/25785826.2022.2137967
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Programmed cell death 1 (PD-1) is an immune checkpoint and has been reported to be associated with several autoimmune diseases. We aimed to investigate the association between human PD-1 gene (PDCD1) polymorphisms and multiple sclerosis (MS). This case-control study was conducted on 229 MS patients and 246 healthy controls. Genotyping of rs36084323 (PD-1.1 G/A), rs11568821 (PD-1.3 G/A) and rs2227981 (PD-1.5 C/T) polymorphisms was performed by PCR-RFLP technique. The frequency difference of PD-1.1 genotypes and alleles (-536 G/A) between patients and healthy controls was not significant. Regarding PD-1.3, the AA + AG genotype was found to be relatively higher in the control group. Concerning PD-1.5 (+7785 C/T), the frequency of T allele carriers (TT + CT) was relatively higher in MS patients, which was marginally insignificant (p = .07). PD-1 gene polymorphisms may be associated with MS; however, accurate conclusions require further studies with a larger number of samples.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 34 条
[1]   Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population [J].
Anderson, DE ;
Bieganowska, KD ;
Bar-Or, A ;
Oliveira, EML ;
Carreno, B ;
Collins, M ;
Hafler, DA .
NATURE MEDICINE, 2000, 6 (02) :211-214
[2]   Programmed cell death 1 gene (PDCD1) polymorphism and pemphigus foliaceus (fogo selvagem) disease susceptibility [J].
Braun-Prado, Karin ;
Petzl-Erler, Maria Luiza .
GENETICS AND MOLECULAR BIOLOGY, 2007, 30 (02) :314-321
[3]   The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes [J].
Cooper, Jason D. ;
Smyth, Deborah J. ;
Bailey, Rebecca ;
Payne, Felicity ;
Downes, Kate ;
Godfrey, Lisa M. ;
Masters, Jennifer ;
Zeitels, Lauren R. ;
Vella, Adrian ;
Walker, Neil M. ;
Todd, John A. .
BMC MEDICAL GENETICS, 2007, 8
[4]   Management of Gene Promoter Mutations in Molecular Diagnostics [J].
de Vooght, Karen M. K. ;
van Wijk, Richard ;
van Solinge, Wouter W. .
CLINICAL CHEMISTRY, 2009, 55 (04) :698-708
[5]   Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus [J].
Fathi, Farshid ;
Sadeghi, Erfan ;
Lotfi, Noushin ;
Hafezi, Hossein ;
Ahmadi, Meysam ;
Mozafarpoor, Samaneh ;
Motedayyen, Hossein .
INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2020, 47 (01) :57-64
[6]   Association of PDCD1 with susceptibility to systemic lupus erythematosus - Evidence of population-specific effects [J].
Ferreiros-Vidal, I ;
Gomez-Reino, JJ ;
Barros, F ;
Carracedo, A ;
Carreira, P ;
Gonzalez-Escribano, F ;
Liz, M ;
Martin, J ;
Ordi, J ;
Vicario, JL ;
Gonzalez, A .
ARTHRITIS AND RHEUMATISM, 2004, 50 (08) :2590-2597
[7]   The PD-1 pathway in tolerance and autoimmunity [J].
Francisco, Loise M. ;
Sage, Peter T. ;
Sharpe, Arlene H. .
IMMUNOLOGICAL REVIEWS, 2010, 236 :219-242
[8]   Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [J].
Freeman, GJ ;
Long, AJ ;
Iwai, Y ;
Bourque, K ;
Chernova, T ;
Nishimura, H ;
Fitz, LJ ;
Malenkovich, N ;
Okazaki, T ;
Byrne, MC ;
Horton, HF ;
Fouser, L ;
Carter, L ;
Ling, V ;
Bowman, MR ;
Carreno, BM ;
Collins, M ;
Wood, CR ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1027-1034
[9]   Program death 1 (PD1) haplotyping in patients with breast carcinoma [J].
Haghshenas, Mohammad Reza ;
Naeimi, Sirous ;
Talei, Abdolrasoul ;
Ghaderi, Abbas ;
Erfani, Nasrollah .
MOLECULAR BIOLOGY REPORTS, 2011, 38 (06) :4205-4210
[10]   PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China [J].
Hua, Zhang ;
Li, Dalin ;
Xiang, Gao ;
Xu, Fengyan ;
Jie, Guan ;
Fu, Zhenkun ;
Jie, Zhang ;
Da, Pang ;
Li, Dianjun .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) :195-201